Efficacy of six-minutes walk test(6MWT) and four meter gait test(4MGT) for stable interstitial pneumonia patient: a prospective observational study

Efficacy of six-minutes walk test(6MWT) and four meter gait test(4MGT) for stable interstitial pneumonia patient: a prospective observational study - Study of 6MWT and 4MGT for IP patient

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000029186

Enrollment

Registered

2017-09-20

Start date

2017-10-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Interestitial Pneumonia(IP)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who are clinically or pathologically diagnosed Interstitial Pneumonia(IP) with the ATS/ERS criteria. 2. Patients who agree to participate in the study with the written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients who diagnosed COPD or Bronchial Asthma. 2. Patients with uncontrolled cardiovascular disease, arrhythmia, or cerebrovascular disease. 3. Patients with skeletal of joint disease and cannot walk. 4. Patients with cognitive impairment or mental disorder and are regarded as impossible to answer the questionnaire of this study. 5. Patients who have experienced a IP exacerbation within the past one month. 6. Any other cases who are regarded as inadequate for the study enrollment by the investigators.

Design outcomes

Primary

Measure	Time frame
Correlation of 6MWT score and 4MGT score	—

Secondary

Measure	Time frame
Correlation of 4MGT and following items 1. Patient profile(age, sex, Height, Body weight, BMI, smoking history, Classification of IP, and treatment) 2. Patients' vital signs(pulse rate, blood pressure, respiration rate, SpO2) 3. Arterial blood gas analysis(pH, PaO2, PaCO2) 4. Pulmonary function(FVC, FEV1.0, DLCO) 5. Muscle weakness(grip, triceps) 6. Skeletal muscle mass index(SMI) 7. Total modified-Medical Reserch Council(mMRC) dyspnea scale score 8. Total St. George's Respiratory Questionaire (SGRQ) score, and each component score (symptom score, activity score, and impact score) 9. Total COPD Assessment Test(CAT) score 10. Physical Activities	—

Measure

Time frame

Correlation of 4MGT and following items 1. Patient profile(age, sex, Height, Body weight, BMI, smoking history, Classification of IP, and treatment) 2. Patients' vital signs(pulse rate, blood pressure, respiration rate, SpO2) 3. Arterial blood gas analysis(pH, PaO2, PaCO2) 4. Pulmonary function(FVC, FEV1.0, DLCO) 5. Muscle weakness(grip, triceps) 6. Skeletal muscle mass index(SMI) 7. Total modified-Medical Reserch Council(mMRC) dyspnea scale score 8. Total St. George's Respiratory Questionaire (SGRQ) score, and each component score (symptom score, activity score, and impact score) 9. Total COPD Assessment Test(CAT) score 10. Physical Activities

—

Countries

Japan

Contacts

Public ContactRyosuke Hirabayashi

Kobe City Medical Center General Hospital Department of Respiratory Medicine

rhirabayashi0405@kcho.jp078-302-4321

Outcome results